enVVeno Medical Valuation

Is NVNO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NVNO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate NVNO's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate NVNO's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NVNO?

Key metric: As NVNO is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for NVNO. This is calculated by dividing NVNO's market cap by their current book value.
What is NVNO's PB Ratio?
PB Ratio	1.2x
Book	US$47.37m
Market Cap	US$59.10m

NVNO key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	n/a
Enterprise Value/EBITDA	-0.5x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does NVNO's PB Ratio compare to its peers?

The above table shows the PB ratio for NVNO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	7353.5x
BEAT HeartBeam	15.7x	48.4%	US$65.9m
IRME IR-Med	29375x	86.4%	US$58.8m
MDNC Medinotec	22.4x	n/a	US$58.7m
RBOT Vicarious Surgical	1x	-3.8%	US$53.3m
NVNO enVVeno Medical	1.2x	32.9%	US$59.1m

Price-To-Book vs Peers: NVNO is good value based on its Price-To-Book Ratio (1.2x) compared to the peer average (9797.2x).

Price to Book Ratio vs Industry

How does NVNO's PB Ratio compare vs other companies in the US Medical Equipment Industry?

28 Companies	Price / Book	Estimated Growth	Market Cap
ADGM Adagio Medical Holdings	0.4x	n/a	US$29.07m
RVP Retractable Technologies	0.2x	n/a	US$17.55m
MHUA Meihua International Medical Technologies	0.1x	n/a	US$16.93m
LFWD Lifeward	0.5x	65.0%	US$16.30m

28 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: NVNO is good value based on its Price-To-Book Ratio (1.2x) compared to the US Medical Equipment industry average (2.5x).

Price to Book Ratio vs Fair Ratio

What is NVNO's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NVNO PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	1.2x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate NVNO's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Elevance Health

US$92.2b

Operates as a health benefits company in the United States.

ELV

US$403.60

-0.8%

-15.9%

Centene

US$29.8b

Operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States.

CNC

US$60.35

2.8%

-18.7%

electroCore

US$64.1m

A commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally.

ECOR

US$9.92

-27.1%

80.4%